A previous investigation has demonstrated that the practice of a meditational technique elicits a wakeful, hypometabolic state. Measurement of O2 consumption and CO2 elimination was made by sampling techniques; mean values of these parameters were calculated from 6–10 minute samples. The present study extends this investigation, using a recently developed method of continuous measurement of O2 consumption and CO2 elimination. Continuous measurement of these parameters permitted the determination of mean values for the entire experimental periods as well as for selected intervals and permitted the examination of the sequence of respiratory changes. The present study reports statistically significant decreases in O2 consumption of 5 percent and CO2 elimination of 6 percent for the entire 20 minutes of the meditation period. These are lower than the sample values of 16 percent and 15 percent reported in the previous study. However, when selected intervals of the meditation period are examined, decreases in O2 consumption and CO2 elimination are comparable to those previously reported. The results are consistent with the difference between the discontinuous sampling measurement method originally employed and the continuous measurement method of the present investigation.
Continuous Measurement of O2 Consumption and CO2 Elimination During a Wakeful Hypometabolic State
Publication
Journal of Human Stress / Behavioral Medicine
Volume 1(1)
Abstract
Web and Email Links
Related Listings
Journal
Neuroscience News
The ability of an adult to learn and to perform cognitive tests is directly linked to how active the brain is at rest, UNSW researchers have found.
Journal
Biofeedback and Self-regulation
The purpose of this study was to assess the central nervous system effects of the relaxation response (RR) in novice subjects using a controlled, within- subjects design and topographic EEG mapping as the dependent measure. Twenty subjects listened to a RR and control audiotape presented in a counterbalanced order while EEG was recorded from 14 scalp locations. The RR condition produced greater (p < .0164) reductions in frontal EEG beta activity relative to the control condition. N […]
Journal
Frontiers in Psychiatry
Background: Obsessive-compulsive disorder (OCD) is often a life-long disorder with high psychosocial impairment. Serotonin reuptake inhibitors (SRIs) are the only FDA approved drugs, and approximately 50% of patients are non-responders when using a criterion of 25% to 35% improvement with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). About 30% are non-responders to combined first-line therapies (SRIs and exposure and response prevention). Previous research (one open, one randomi […]

